FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia. Sung PJ, Selvam M, Riedel SS, Xie HM, et al. Leukemia 2024 Jan 5. doi: 10.1038/s41375-023-02131.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sung PJ, Selvam M, Riedel SS, Xie HM, et al. FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia. Leukemia 2024 Jan 5. doi: 10.1038/s41375-023-02131.
PMID: 38182819